Why is APUS Up Today?
About Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals Us Inc is a clinical-stage company. It is engaged in a pharmaceutical business that provides the biological drug Apitox to clients in the biological drug commercial transaction area. It are a clinical stage biopharmaceutical company in the process of developing Apitox, an int...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
ACCUMULATION - This move is backed by significant volume and appears sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.1%
Market Comparison
Quick Trade Ideas
Options strategies to consider for APUS's 7% move
No Options Available
APUS doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get APUS Alerts
We'll notify you when APUS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
APUS has moved more than 3.0% up on 64 occasions in the past year.
Frequently Asked Questions
Why is APUS stock up today?
This stock is significantly outperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is APUS stock a buy or sell right now?
Based on current analysis, APUS shows 65% confidence in today's move. Volume is high which supports the trend. View full buy/sell analysis →
What is the APUS stock price target?
APUS is currently trading at $1.80. Based on today's momentum, the expected short-term range is $1.76 - $1.85. See long-term price prediction →
Will APUS stock continue rising?
Our analysis shows a 65% probability that APUS's move continues in the next 1-3 days. Key level to watch: $1.88 (resistance).
Is APUS stock oversold or overbought?
APUS's RSI (Relative Strength Index) is currently at 31.9. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for APUS stock?
APUS's 10-day momentum indicator is at -0.71. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is APUS outperforming or underperforming the market?
APUS (+7.49%) is currently significantly outperforming the market (+7.6% vs SPY). Today, the S&P 500 (SPY) is down -0.12%, and Nasdaq (QQQ) is up 0.63%.
What does MACD indicate for APUS?
APUS's MACD (-0.58) is currently below the signal line (-0.43), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 21.7) is moderate.
Is APUS in an uptrend or downtrend?
Based on moving average analysis, APUS is in a bearish trend. The price ($1.80) is trading below both the 20-day SMA ($2.98) and 50-day SMA ($3.31). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis